IRS1 and polycystic ovary syndrome: Indeed, studies of skeletal muscle biopsies from women with PCOS have reported constitutive activation of kinases in the mitogenic MAPK-ERK 1 and 2 pathway, contributing to serine phosphorylation of IRS-1 with consequent inhibition of metabolic signaling in muscle tissue [44–46].